DI MAIO, M.; DANIELE, G.; PICCIRILLO, M. Impact on health-related quality of life of the addition of bevacizumab to first-line chemotherapy for ovarian cancer:  . Cancer Breaking News, [S. l.], v. 1, n. 1, p. 33–35, 2013. Disponível em: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/254. Acesso em: 3 jul. 2024.